Real-life durability and risk factors for biologic discontinuation in pediatric inflammatory bowel disease: results from the SIGENP IBD registry.
Lega S, Dipasquale V, D'arcangelo G, Scarallo L, Ancona S, Fedele F, Zuin G, Graziano F, Norsa L, Gatti S, Illiceto MT, Felici E, Corpino M, Pavanello PM, Cozzali R, Alvisi P, Pizzol A, Banzato C, Penagini F, Marseglia A, Faraci S, Luini C, Strisciuglio C, Moretti C, Martinelli M, Arrigo S, Lionetti P, Aloi M, Romano C, Giangreco M, Bramuzzo M; SIGENP IBD Study Group.
Lega S, et al. Among authors: banzato c.
J Crohns Colitis. 2025 Sep 28;19(9):jjaf164. doi: 10.1093/ecco-jcc/jjaf164.
J Crohns Colitis. 2025.
PMID: 40973671